Short term health-related quality-of-life in men with metastatic castration-resistant prostate cancer treated with first-line enzalutamide or abiraterone plus prednisone: A systema... by K. Ternov Kvorning, A.B. Nolsøe, O. Bratt, M. Fode, H. Lindberg, C. Kistorp, G. Palapattu, T.W. Klausen, J. Sønksen, P.B. Østergren

Get full text